“Optime Care is committed to serving rare patient populations who rely on copay assistance to pay for much-needed specialty drugs,” continues Burt.
She points out that health equity has become a primary concern for millions of Americans who rely upon copay assistance to afford their prescribed medications. Our goal is to continuously support our partners with these types of programs and services that streamline access to branded therapies and enhance patient outcomes.” “This is another service we can offer to new partners, as well as companies where we have deep longstanding relationships. “This program comes at an ideal time, and we are excited to respond to the growing and often unanswered needs in the marketplace in order to support manufacturers in limiting their potential exposure relating to copay accumulator and maximizer programs,” says Tiffany Ellen Burt, President and Chief Operating Officer, Optime Care. Utilizing proprietary block-chain technology as its backbone, Copay Advisor SM minimizes potentially negative exposure with co-pay and maximizer programs for pharmaceutical manufacturers. Earth City, MO – – Optime Care, a nationally recognized specialty pharmacy, distribution and patient management organization maximizing therapeutic opportunities for the treatment of orphan and rare disorders, announces the launch of Copay Advisor SM, a first-in-class, innovative copay assistance program to proactively address challenges and unmet needs of its drug manufacturer partners.
0 kommentar(er)
